Why Medical Software Can Be a Strong Investment Opportunity: What Inveready Saw in StereoDive
StereoDive will join Capital Cell and Inveready for an investor webinar on 17 June to explore how professional investors assess medical software companies and why StereoDive fits this investment thesis.
StereoDive to Participate in Capital Cell’s Demo Day: Investing in Biotech
StereoDive will participate in Capital Cell’s online Demo Day: Investing in Biotech on June 9, presenting its investment opportunity alongside selected European biotech, healthtech and life sciences startups.
StereoDive Launches Capital Cell Campaign to Accelerate Neurosurgical Planning Software
StereoDive has opened an investment round on Capital Cell to support the development and commercialisation of stereoDiver, its medical software platform for stereotactic neurological procedure planning.